nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CYP2C19—Acetylsalicylic acid—Kawasaki disease	0.511	0.546	CbGbCtD
Tolterodine—CYP2C9—Acetylsalicylic acid—Kawasaki disease	0.425	0.454	CbGbCtD
Tolterodine—KCNH2—endocardium—Kawasaki disease	0.0442	0.69	CbGeAlD
Tolterodine—CHRM5—skin of body—Kawasaki disease	0.00482	0.0753	CbGeAlD
Tolterodine—KCNH2—cardiac ventricle—Kawasaki disease	0.00372	0.0581	CbGeAlD
Tolterodine—KCNH2—myocardium—Kawasaki disease	0.0035	0.0546	CbGeAlD
Tolterodine—CHRM2—heart—Kawasaki disease	0.00338	0.0528	CbGeAlD
Tolterodine—KCNH2—heart—Kawasaki disease	0.00244	0.0381	CbGeAlD
Tolterodine—CYP2C9—heart—Kawasaki disease	0.00198	0.031	CbGeAlD
